Knockdown of cytosolic glutaredoxin 1 leads to loss of mitochondrial membrane potential: implication in neurodegenerative diseases
about
Mechanisms of altered redox regulation in neurodegenerative diseases--focus on S--glutathionylationProtein-thiol oxidation and cell death: regulatory role of glutaredoxinsRedox regulation of mitochondrial functionProteomic analysis of PKCγ-related proteins in the spinal cord of morphine-tolerant ratsSystemic remodeling of the redox regulatory network due to RNAi perturbations of glutaredoxin 1, thioredoxin 1, and glucose-6-phosphate dehydrogenasePlant toxin β-ODAP activates integrin β1 and focal adhesion: A critical pathway to cause neurolathyrismA disruption in iron-sulfur center biogenesis via inhibition of mitochondrial dithiol glutaredoxin 2 may contribute to mitochondrial and cellular iron dysregulation in mammalian glutathione-depleted dopaminergic cells: implications for Parkinson's dBeyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases.Role of glutaredoxin1 and glutathione in regulating the activity of the copper-transporting P-type ATPases, ATP7A and ATP7B.MAP4 mechanism that stabilizes mitochondrial permeability transition in hypoxia: microtubule enhancement and DYNLT1 interaction with VDAC1.Swapping of the N-terminus of VDAC1 with VDAC3 restores full activity of the channel and confers anti-aging features to the cell.Glutaredoxin 2 prevents aggregation of mutant SOD1 in mitochondria and abolishes its toxicity.Molecular biology research in neuropsychiatry: India's contributionLevodopa deactivates enzymes that regulate thiol-disulfide homeostasis and promotes neuronal cell death: implications for therapy of Parkinson's disease.Thiol redox homeostasis in neurodegenerative diseaseReduced mtDNA copy number increases the sensitivity of tumor cells to chemotherapeutic drugs.Mitochondrial thiols in the regulation of cell death pathways.Thiol-redox signaling, dopaminergic cell death, and Parkinson's diseaseGlutaredoxin 1 protects dopaminergic cells by increased protein glutathionylation in experimental Parkinson's disease.Nitrated {alpha}-synuclein-induced alterations in microglial immunity are regulated by CD4+ T cell subsetsRegional variations of antioxidant capacity and oxidative stress responses in HIV-1 transgenic rats with and without methamphetamine administration.SR/ER-mitochondrial local communication: calcium and ROS.Mitochondrial energy metabolism and redox signaling in brain aging and neurodegenerationLipoic acid: energy metabolism and redox regulation of transcription and cell signalingLevodopa activates apoptosis signaling kinase 1 (ASK1) and promotes apoptosis in a neuronal model: implications for the treatment of Parkinson's disease.Glutaredoxin1 protects neuronal cells from copper-induced toxicity.VDAC1 cysteine residues: topology and function in channel activity and apoptosis.Outer membrane VDAC1 controls permeability transition of the inner mitochondrial membrane in cellulo during stress-induced apoptosis.Antipsychotic drug-associated gene-miRNA interaction in T-lymphocytes.Synergism of co-delivered nanosized antioxidants displayed enhanced anticancer efficacy in human colon cancer cell lines.Thymoquinone increases the expression of neuroprotective proteins while decreasing the expression of pro-inflammatory cytokines and the gene expression NFκB pathway signaling targets in LPS/IFNγ -activated BV-2 microglia cells.
P2860
Q26830954-D638D0E8-2143-463C-AA82-917E40EA5334Q26852767-9BA4A97D-484B-49DE-9FFD-9EBDFBFFC0BFQ28383361-7DEE6E3D-7F90-43CC-8E9D-87CC986E2BDFQ28481707-1854E268-9620-4C42-9E01-74E71B2CEB2DQ31034705-0400E296-1847-41CC-A15D-1493A9DD8BD7Q31155029-87C91B23-83BF-4831-BA9E-3CAD2CF7A55CQ33644307-A4B66F04-1B89-42FB-A158-55F7C06BE792Q34020244-22DBE227-D0DC-49A0-BEBC-95BF1F79927DQ34094489-F375B7EC-C887-4569-9900-8AB982D6F4ECQ34098965-2967F4D5-9A7F-4BB5-9228-55EF43CE54D4Q34113154-5D0D75C4-BE20-4C38-A8B4-88B72EC926A3Q34137069-2E9F4DF5-32ED-4F6F-B214-101726EA6D89Q35135505-135A605D-6D5B-4EFA-96A9-0F56FD823805Q35448162-526DEEC7-871F-4D99-89B3-1D337D292C2DQ35614227-2A609938-F93C-4C49-934F-E69EC49D6A4CQ36293279-6555AEF2-39F7-4C8F-9E2D-EA255E792E76Q36326523-C0C9D9E8-A026-4CA8-B835-2B838EFCFCCFQ36326535-DB21FC73-4EAA-4749-BB97-A9067E2E6098Q36326552-6465CDE1-9540-4779-A74D-3FA9CB8BAA3FQ37137351-239FCBB5-CD6C-42E8-A5B5-23E752B375C9Q37172356-6856DBD8-88A7-4E0F-BE9C-2ABBA2782CBCQ37335548-3CFF8D48-F81C-449A-A112-2058A1147C5FQ37460232-EE2A9623-5B5B-4997-9AE6-8DB638A556D2Q37836402-E7C4140F-B5D1-42EC-AE73-BFDA7865CD71Q38753946-0625C498-679A-42F3-A900-53C66613FC7CQ38996178-6EEF3B2C-7824-4803-AF12-D8A4EE9D0229Q43146167-7AC4F8CA-855E-4C65-8145-F3300DEDBB8DQ43294877-E409D677-9F70-4A7B-9EAA-20A2B03DCD74Q54225210-E7EB702E-2B03-4EF4-8B00-DC853BFEC5C6Q54943204-F2008ED9-FEAA-48EE-A6D4-E54D579282DFQ55686847-28C81CA9-F2E1-4E08-A47C-A07D3E541930
P2860
Knockdown of cytosolic glutaredoxin 1 leads to loss of mitochondrial membrane potential: implication in neurodegenerative diseases
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Knockdown of cytosolic glutare ...... in neurodegenerative diseases
@ast
Knockdown of cytosolic glutare ...... in neurodegenerative diseases
@en
type
label
Knockdown of cytosolic glutare ...... in neurodegenerative diseases
@ast
Knockdown of cytosolic glutare ...... in neurodegenerative diseases
@en
prefLabel
Knockdown of cytosolic glutare ...... in neurodegenerative diseases
@ast
Knockdown of cytosolic glutare ...... in neurodegenerative diseases
@en
P2093
P2860
P1433
P1476
Knockdown of cytosolic glutare ...... in neurodegenerative diseases
@en
P2093
Dinesh C Joshi
Lalitha Durgadoss
Preeti G Joshi
R Khader Valli
Uzma Saeed
P2860
P356
10.1371/JOURNAL.PONE.0002459
P407
P577
2008-06-18T00:00:00Z